The Institute of Medicine (IOM) recently announced the names of 70 new members and 10 foreign associates during its 42nd Annual Meeting, in Washington, DC. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
“The Institute of Medicine is greatly enriched by the addition of our newly elected colleagues, each of whom has significantly advanced health and medicine,” said IOM President Harvey V. Fineberg, MD, PhD.
The newly elected members raise IOM’s total active membership to 1,732 and the number of foreign associates to 112.
New Members Active in Cancer-related Pursuits
Newly elected IOM members working in oncology/hematology and other cancer-related fields include:
- R. Daniel Beauchamp, MD, FACS, Vanderbilt University Medical Center, Nashville, Tennessee
- Shelley L. Berger, PhD, University of Pennsylvania, Philadelphia
- Bruce R. Blazar, MD, University of Minnesota, Minneapolis
- John M. Carethers, MD, University of Michigan Health System, Ann Arbor
- Lynda Chin, MD, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston
- Don W. Cleveland, PhD, Ludwig Institute for Cancer Research, La Jolla, California, and University of California, San Diego
- Lisa DeAngelis, MD, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York
- Vishva M. Dixit, MD, Genentech Inc, San Francisco
- Jennifer R. Grandis, MD, FACS, University of Pittsburgh School of Medicine, Pittsburgh
- Donald E. Ingber, MD, PhD, Harvard Medical School and Children’s Hospital, Boston
- Carl H. June, MD, Perelman School of Medicine and Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia
- Daniel L. Kastner, MD, PhD, National Human Genome Research Institute and National Institutes of Health, Bethesda, Maryland
- Paula M. Lantz, PhD, George Washington University, Washington, DC
- Terry R. Magnuson, PhD, School of Medicine, University of North Carolina, Chapel Hill
- Andrew I. Schafer, MD, Weill Cornell Medical College and New York Presbyterian Hospital, New York
- Mitchell D. Schnall, MD, PhD, Perelman School of Medicine, University of Pennsylvania, Philadelphia
- Gregg L. Semenza, MD, PhD, Johns Hopkins University School of Medicine, Baltimore
- Diana J. Wilkie, RN, PhD, FAAN, Center for Excellence for End-of-Life Transition Research and College of Nursing, University of Illinois, Chicago ■
